Dr. William K. Fleming is President, Pharmacy Solutions, and Chief Corporate Affairs Officer for Humana. William is a member of the Management Team, which sets the firm’s strategic direction, and reports to President and Chief Executive Officer Bruce Broussard.
In over two decades at Humana, William has spent the majority of his career pioneering Humana’s pharmacy business and bringing forward a clinical integration belief to drive a total cost-of-care and health outcomes view of the world. In 2017, William expanded his leadership to include a focus in Humana’s home business, behavioral health business, clinical care businesses, and advanced clinical analytics. Later in 2019, William evolved his responsibility to the transformation of the Clinical Solutions (strategy, quality, and trend), the transformation of the Pharmacy Solutions (PBM, mail, specialty, retail), and delivery of the company’s enterprise clinical operating model (ECOM).
William has a passion for using an entrepreneurial spirit in simplifying healthcare, providing value for consumers (both the patient and the physician), and developing high performing teams that share the common goal of improving health outcomes and clinical quality.
William received his BS Pharmacy from the University Of Kentucky College Of Pharmacy, where he went on to receive his Doctor of Pharmacy (PharmD). He also holds a BA in General Studies from Transylvania University. William has held numerous prior Board/Trustee appointments to various pharmacy and charity organizations, including currently serving as a Board member on the Pharmaceutical Care Management Association (PCMA). Recognizing his commitment to the transformation in pharmacy, William has also been named a Fellow in the Academy of Managed Care Pharmacy (FAMCP).
William resides in Prospect, Kentucky with his wife, Nancy, and their three children (Meredith, Hunter, and Teagan), along with the family dog (Gemma). He is an avid runner, having completed many marathons and even more half-marathons, and is occasionally found on his local golf course (Big Spring at Harmony Landing Campus). In his spare time, he enjoys spending time with his family, attending church, thriving on Louisville’s local food scene, and cheering for his beloved University of Kentucky Wildcats.
What is William Kevin Fleming's net worth?
The estimated net worth of William Kevin Fleming is at least $628,128.20 as of November 3rd, 2022. Dr. Fleming owns 2,542 shares of Humana stock worth more than $628,128 as of December 21st. This net worth estimate does not reflect any other assets that Dr. Fleming may own. Learn More about William Kevin Fleming's net worth.
How do I contact William Kevin Fleming?
Has William Kevin Fleming been buying or selling shares of Humana?
William Kevin Fleming has not been actively trading shares of Humana during the past quarter. Most recently, William Kevin Fleming sold 11,157 shares of the business's stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $565.61, for a transaction totalling $6,310,510.77. Following the completion of the sale, the chief accounting officer now directly owns 2,542 shares of the company's stock, valued at $1,437,780.62. Learn More on William Kevin Fleming's trading history.
Who are Humana's active insiders?
Humana's insider roster includes Roy Beveridge (Insider), Jody Bilney (Insider), Bruce Broussard (CEO), M. Christopher (Insider), Samir Deshpande (Insider), Susan Diamond (CFO), William Fleming (CAO), Christopher Hunter (Insider), Timothy Huval (Insider), David Jones, Jr. (Director), Heidi Margulis (Insider), Jorge Mesquita (Director), James Murray (COO), Joseph Ventura (Insider), and Timothy Wheatley (Insider). Learn More on Humana's active insiders.
Are insiders buying or selling shares of Humana?
During the last twelve months, Humana insiders bought shares 1 times. They purchased a total of 545 shares worth more than $200,064.05. The most recent insider tranaction occured on February, 20th when Director Jorge S Mesquita bought 545 shares worth more than $200,064.05. Insiders at Humana own 0.3% of the company.
Learn More about insider trades at Humana. Information on this page was last updated on 2/20/2024.
